VIRTUAL REBELION

$KRTL has strategically positioned itself in Bolivia because it has an abundant biodiversity, which could be a valuable resource for API production, especially for plant-based or naturally derived pharmaceutical ingredients. Setting up infrastructure there could provide several strategic advantages for the U.S. market: 1.Diversification from China & India: By establishing an API supply chain in Bolivia, KRTL reduces dependency on traditional pharmaceutical hubs and mitigates risks from tariffs or geopolitical tensions. 2.Access to Unique Natural Resources: Bolivia’s rainforests and Andean ecosystems offer a rich source of bioactive compounds that could be leveraged for novel drug development. 3.Cost-Effective Production: Labor and operational costs in Bolivia are lower than in the U.S. or Europe, making it a financially attractive option for pharmaceutical manufacturing.